Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
LARC prolongs interpregnancy intervals but doesn’t cut preterm birth risk
Key clinical point: LARC use between pregnancies reduces short interpregnancy intervals, but not preterm birth risk.
Major finding: LARC exposure was associated with significantly reduced likelihood of short interpregnancy intervals (P less than .0001).
Study details: A retrospective cohort study of records for more than 35,000 women.
Disclosures: Dr. Simonsen and Dr. Espey reported having no relevant disclosures.
Citation:
REPORTING FROM ACOG 2019